Ranbaxy Laboratories reports consolidated net loss of Rs 185.92 crore in Q1FY15

30 Jul 2014 Evaluate

Ranbaxy Laboratories has reported results for first quarter ended June 30, 2014.

The company has reported net profit of Rs 755.12 crore for the quarter under review as compared to a net loss of Rs 608.80 crore for the quarter ended June 30, 2013. The company’s total income has increased by 49.96% to Rs 2204.39 crore for the quarter under review from Rs 1469.93 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported a net loss after taxes and Minority Interest and Share of Profit of Associates of Rs 185.92 crore for the quarter as compared to net loss of Rs 524.24 crore for the same quarter in the previous year. Besides, total income of the company has decreased by 8.16% at Rs 2451.70 crore for quarter under review as compared to Rs 2669.58 crore for the quarter ended June 30, 2013.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×